灵康药业：第四届监事会第二十次会议决议公告

Core Viewpoint - Lingkang Pharmaceutical announced the approval of the "2025 Semi-Annual Report and Summary" by its fourth supervisory board's 20th meeting [2] Group 1 - The company held a supervisory board meeting to review and approve the semi-annual report [2]